Skip to content

The effect of Lavender on mood disorders and sexual Function along with the use of combined oral contraceptive pills (COCs)

The effect of Lavender on mood disorders and sexual Function along with the use of combined oral contraceptive pills (COCs) : A triple-blind, randomized, controlled trial

Status
Recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT20110606006709N24
Enrollment
60
Registered
2022-04-19
Start date
2022-04-30
Completion date
Unknown
Last updated
2022-05-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Condition 1: Mood disorders. Condition 2: Sexual dysfunction. Persistent mood [affective] disorders Sexual dysfunction not due to a substance or known physiological condition

Interventions

Intervention 1: Intervention group: Gelatin capsule containing 80 mg of lavender essential oil daily for 8 weeks. Medicines will be made by Barij Essential Pharmaceutical Company. Intervention 2: Cont

Sponsors

Tabriz University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
15 Years to 49 Years

Inclusion criteria

Inclusion criteria: Being married and having sexual activity The reason for taking COCs(Combined Oral Contraceptives)is contraception. Has used COC for at least the past month. By completing the PANAS(Positive And Negative Affect Schedule) questionnaire, the score obtained from the negative emotion part is higher than the positive emotion. The score obtained from completing the Female Sexual Function Index (FSFI) will be 28 and less. The participant must have a telephone number and one of the Internet communication programs for exchanging photos of questionnaires (WhatsApp, Telegram, etc.).

Exclusion criteria

Exclusion criteria: Unpleasant events such as the death of a family member at least 3 months before the start of the study Use other conventional methods to control the effects of COCs(Combined Oral Contraceptives) Allergy to herbal medicines Use of drugs that affect sexual function (sildenafil, antidepressants, antihistamines, diazepines, barbiturates, amphetamines, antihypertensive drugs, cocaine, thiazide diuretics, narcotics, etc.) Any diagnosis of mental health problems within 6 months prior to the study Severe or very severe depression characterized by a score greater than 21 on the DASS-21(Depression, Anxiety, Stress Scale-21) questionnaire Use of cigarettes, hookah, opium, etc. and psychotherapy or any sedative Take multivitamin tablets

Design outcomes

Primary

MeasureTime frame
Score of mood disorders. Timepoint: Before and after the intervention every 14 days during the 56-day period. Method of measurement: PANAS(Positive And Negative Affect Schedule) questionnaire.;Sexual function score. Timepoint: Before the intervention and every 28 days after intervention for a period of 56 days. Method of measurement: FSFI(Female Sexual Function Index) questionnaire.

Secondary

MeasureTime frame
Sleep quality score. Timepoint: Before and after the intervention every 28 days for a period of 56 days. Method of measurement: PASQI(Pittsburgh Sleep Quality Index) questionnaire.;Anxiety, stress and depression scores. Timepoint: Before and after the intervention every 14 days for a period of 56 days. Method of measurement: DASS-21(Depression Anxiety, Stress, Scale-21) questionnaire.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMina Naghdi

Tabriz University of Medical Sciences

mnnghd2019@gmail.com+98 41 3475 3906

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026